Darlene Noci - Jul 7, 2022 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
SVP of Product Development & Regulatory Affairs Exhibit List: Exhibit 24 - Limited Power of Attorney
Signature
/s/ Deborah A. Miller, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Jul 7, 2022
Transactions value $
-$277,704
Form type
4
Date filed
7/8/2022, 04:17 PM
Previous filing
Feb 16, 2022
Next filing
Jul 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $18.1K +16.8K $1.08* 16.8K Jul 7, 2022 Direct F1
transaction NUVL Class A Common Stock Sale -$296K -16.8K -100% $17.61 0 Jul 7, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -16.8K -10.1% $0.00 150K Jul 7, 2022 Class A Common Stock 16.8K $1.08 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2021.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.05 to $18.06, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
F3 The shares underlying this option vest as follows: 25% of the shares vested on January 11, 2022, and the remainder vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Remarks:

SVP of Product Development & Regulatory Affairs Exhibit List: Exhibit 24 - Limited Power of Attorney